tungsten has been researched along with Chronic Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbier, O; Chen, N; Dubuissez, M; Gerarduzzi, C; Grant, MP; Hartmann, U; Henley, N; Pichette, V; Royal, V | 1 |
| Fox, J; Hamman, RF; James, KA; Johnson, RJ; Macaluso, F; Mesenbring, E; Moore, C | 1 |
2 other study(ies) available for tungsten and Chronic Kidney Diseases
| Article | Year |
|---|---|
Subchronic oral exposure of tungsten induces myofibroblast transformation and various markers of kidney fibrosis.
Topics: Administration, Oral; Animals; Dose-Response Relationship, Drug; Fibrosis; Male; Mice; Mice, Inbred C57BL; Myofibroblasts; NIH 3T3 Cells; Renal Insufficiency, Chronic; Toxicity Tests, Subchronic; Tungsten | 2022 |
Urine tungsten and chronic kidney disease in rural Colorado.
Topics: Colorado; Humans; Kidney; Prospective Studies; Renal Insufficiency, Chronic; Risk Factors; Tungsten | 2021 |